Early Outcomes Reported From Postmarket ROADSTER 2 Study of Silk Road Medical’s Enroute TCAR Devices
August 19, 2020—Silk Road Medical, Inc. announced that early outcomes from the ROADSTER 2 postmarket study of transcarotid artery revascularization (TCAR) have been published by Vikram S. Kashyap, MD, et al in Stroke (2020;51:2620-2629).